Structures by: Minas da Piedade M. A.
Total: 20
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0524(2)Å b=16.3826(5)Å c=23.4238(7)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=5.9874(5)Å b=16.1056(15)Å c=23.4443(19)Å
α=90° β=90.04(2)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0018(6)Å b=16.139(2)Å c=23.448(3)Å
α=90.000(7)° β=90.032(7)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0587(3)Å b=16.4386(10)Å c=23.3475(14)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.1145(2)Å b=17.2901(6)Å c=22.4334(8)Å
α=90° β=90° γ=90°
[Fe(5-Br-salEen)2]ClO4
[Fe(5BrsalEen)2]ClO4
Chem. Sci. (2016) 7, 7 4251
a=10.3027(4)Å b=14.2644(6)Å c=18.1624(7)Å
α=90° β=90° γ=90°
C22H28Br2ClFeN4O6
C22H28Br2ClFeN4O6
Chem. Sci. (2016) 7, 7 4251
a=11.931(3)Å b=12.170(3)Å c=19.166(5)Å
α=90° β=90° γ=90°
C6H5NO3
C6H5NO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=6.976(2)Å b=11.231(5)Å c=16.290(6)Å
α=82.55(2)° β=78.279(17)° γ=75.166(15)°
C6H4ClNO3
C6H4ClNO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=5.469(2)Å b=10.529(4)Å c=11.795(4)Å
α=90.00° β=97.72(2)° γ=90.00°
C6H5NO3
C6H5NO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=3.7970(10)Å b=7.354(2)Å c=20.905(4)Å
α=90.00° β=90.007(11)° γ=90.00°
C6H5NO3
C6H5NO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=3.804(3)Å b=14.582(7)Å c=10.673(6)Å
α=90.00° β=94.254(18)° γ=90.00°
C24H16
C24H16
The journal of physical chemistry. A (2006) 110, 6 2299-2307
a=7.8270(5)Å b=4.8647(5)Å c=20.2212(16)Å
α=90.000(8)° β=92.791(6)° γ=90.000(7)°
C6H7NO4
C6H7NO4
CrystEngComm (2019) 21, 13 2220
a=4.4942(6)Å b=16.396(2)Å c=9.0283(12)Å
α=90° β=89.977(7)° γ=90°
C8H11NO4S
C8H11NO4S
CrystEngComm (2019) 21, 13 2220
a=5.2638(7)Å b=22.580(3)Å c=8.5353(11)Å
α=90° β=93.269(7)° γ=90°
C6H7NO4
C6H7NO4
CrystEngComm (2019) 21, 13 2220
a=4.50390(10)Å b=16.3890(6)Å c=8.8561(3)Å
α=90° β=91.271(2)° γ=90°
C8H11NO4S
C8H11NO4S
CrystEngComm (2019) 21, 13 2220
a=5.2351(3)Å b=22.4779(13)Å c=8.4174(5)Å
α=90° β=94.301(4)° γ=90°
C6H6NO3.5
C6H6NO3.5
Crystal Growth & Design (2011) 11, 7 2803
a=7.227(3)Å b=23.701(11)Å c=3.6999(16)Å
α=90.00° β=90.00° γ=90.00°
C8H11O3.5
C8H11O3.5
Crystal Growth & Design (2010) 10, 7 3070
a=5.7749(4)Å b=7.2971(5)Å c=10.2251(7)Å
α=76.308(4)° β=84.513(4)° γ=77.722(4)°
C48H42BCuF4N2P2
C48H42BCuF4N2P2
Dalton Transactions (2021)
a=14.5822(5)Å b=14.8285(5)Å c=20.4738(7)Å
α=90° β=110.419(2)° γ=90°
C57H46BCl2CuF4N4P2
C57H46BCl2CuF4N4P2
Dalton Transactions (2021)
a=12.8537(5)Å b=13.6470(5)Å c=15.3142(5)Å
α=84.236(2)° β=81.1860(10)° γ=78.631(2)°